Longitudinal neuroimaging evaluation of the corticospinal tract in patients with stroke treated with autologous bone marrow cells
© 2021 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals LLC on behalf of AlphaMed Press..
Bone marrow mononuclear cells (MNCs) attenuate secondary degeneration and enhance recovery in stroke animal models. In a nonrandomized clinical trial, we imaged 37 patients with stroke: 17 patients treated with MNCs (treated) and 20 patients who received standard of care (nontreated) at 1, 3, and 12 months onset of stroke on 3.0T MRI system. Three-dimensional anatomical and diffusion tensor images were obtained. The integrity of the corticospinal tract was assessed by measuring absolute and relative fractional anisotropy (FA) and mean diffusivity (MD) in the rostral pons (RP), posterior limb of the internal capsule, and corona radiata by drawing regions of interest. Infarct volume and stroke severity, which was assessed via the NIH Stroke Scale (NIHSS), were higher in the MNC group compared with the nontreated patients, which is a major limitation. Overall, the relative FA (rFA) of the nontreated patients exhibited continued reduction and an increase in relative MD (rMD) from 1 to 12 months, whereas despite larger infarcts and higher severity, treated patients displayed an increase in rFA from 3 to 12 months and no change in rMD. Contrary to the nontreated group, the treated patients' rFA was also significantly correlated (P < .05) with NIHSS score in the RP at all time points, whereas rMD at the last two.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Stem cells translational medicine - 10(2021), 7 vom: 03. Juli, Seite 943-955 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Haque, Muhammad E [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cell therapy |
---|
Anmerkungen: |
Date Completed 23.03.2022 Date Revised 23.03.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/sctm.20-0369 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM322463459 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM322463459 | ||
003 | DE-627 | ||
005 | 20231225182107.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/sctm.20-0369 |2 doi | |
028 | 5 | 2 | |a pubmed24n1074.xml |
035 | |a (DE-627)NLM322463459 | ||
035 | |a (NLM)33689219 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Haque, Muhammad E |e verfasserin |4 aut | |
245 | 1 | 0 | |a Longitudinal neuroimaging evaluation of the corticospinal tract in patients with stroke treated with autologous bone marrow cells |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.03.2022 | ||
500 | |a Date Revised 23.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals LLC on behalf of AlphaMed Press. | ||
520 | |a Bone marrow mononuclear cells (MNCs) attenuate secondary degeneration and enhance recovery in stroke animal models. In a nonrandomized clinical trial, we imaged 37 patients with stroke: 17 patients treated with MNCs (treated) and 20 patients who received standard of care (nontreated) at 1, 3, and 12 months onset of stroke on 3.0T MRI system. Three-dimensional anatomical and diffusion tensor images were obtained. The integrity of the corticospinal tract was assessed by measuring absolute and relative fractional anisotropy (FA) and mean diffusivity (MD) in the rostral pons (RP), posterior limb of the internal capsule, and corona radiata by drawing regions of interest. Infarct volume and stroke severity, which was assessed via the NIH Stroke Scale (NIHSS), were higher in the MNC group compared with the nontreated patients, which is a major limitation. Overall, the relative FA (rFA) of the nontreated patients exhibited continued reduction and an increase in relative MD (rMD) from 1 to 12 months, whereas despite larger infarcts and higher severity, treated patients displayed an increase in rFA from 3 to 12 months and no change in rMD. Contrary to the nontreated group, the treated patients' rFA was also significantly correlated (P < .05) with NIHSS score in the RP at all time points, whereas rMD at the last two | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a cell therapy | |
650 | 4 | |a corticospinal tract | |
650 | 4 | |a diffusion tensor imaging | |
650 | 4 | |a ischemic stroke | |
650 | 4 | |a serial neuroimaging study | |
700 | 1 | |a Hasan, Khader M |e verfasserin |4 aut | |
700 | 1 | |a George, Sarah |e verfasserin |4 aut | |
700 | 1 | |a Sitton, Clark |e verfasserin |4 aut | |
700 | 1 | |a Boren, Seth |e verfasserin |4 aut | |
700 | 1 | |a Arevalo, Octavio D |e verfasserin |4 aut | |
700 | 1 | |a Vahidy, Farhaan |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Xu |e verfasserin |4 aut | |
700 | 1 | |a Cox, Charles S |c Jr |e verfasserin |4 aut | |
700 | 1 | |a Alderman, Susan |e verfasserin |4 aut | |
700 | 1 | |a Aronowski, Jaroslaw |e verfasserin |4 aut | |
700 | 1 | |a Grotta, James C |e verfasserin |4 aut | |
700 | 1 | |a Savitz, Sean I |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Stem cells translational medicine |d 2012 |g 10(2021), 7 vom: 03. Juli, Seite 943-955 |w (DE-627)NLM217286267 |x 2157-6580 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2021 |g number:7 |g day:03 |g month:07 |g pages:943-955 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/sctm.20-0369 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2021 |e 7 |b 03 |c 07 |h 943-955 |